Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Neuronetics, Inc.STIM · Entity 6248 | EVP, CFO and Treasurer | May 12, 2025 | May 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Neuronetics, Inc.
Report date May 12, 2025 · Filed May 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 410,053 |
Ending reported balance
After 2025-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-05-12 · Sale · Disposed 193,460 · Balance 416,593 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.46 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2025-05-13 · Sale · Disposed 6,540 · Balance 410,053 F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.17 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.46 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.17 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2025 Filed May 14, 2025 17:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,540 | $4.16 | $27,206.40 |
DisclosureSEC source: 0000950170-25-071591 · ownership.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,053 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.17 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 12, 2025 Filed May 14, 2025 17:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 193,460 | $4.27 | $826,074.20 |
DisclosureSEC source: 0000950170-25-071591 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,593 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.46 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 17:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,867 | $4.48 | $8,364.16 |
DisclosureSEC source: 0000950170-25-034871 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,053 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.72 to $4.32. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 17:46 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028002 · ownership.xml · derivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · shares: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F3 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. F4 · derivative.expiration_date: Represents a PRSU award granted on February 24, 2025 and vesting in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% and 110% of the target for each fiscal year ending December 31, 2025, 2026 and 2027. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 17:46 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 157,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028002 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 611,920 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 24, 2026, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 24, 2025 Filed Mar 13, 2025 17:28 UTC Amendment | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 78,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-038909 · ownership.xml · derivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,750 Underlying: Common Stock · 78,750 shares Expires 2028-07-01 F1 · shares: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.exercise_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. F1 · derivative.expiration_date: The Form 4 filed on February 26, 2025 inadvertently reported that the performance restricted stock unit ("PRSU") award granted on February 24, 2025 vests in 1/3 tranches on December 31, 2027, 2026 and 2027, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The correct vesting dates are December 31, 2025, 2026 and 2027. The Form 4 also reported that the Reporting Person receives a percentage of each vesting if the Issuer's year-end cash balance is between 80% (the "Threshold Achievement") and 110% of the target for each vesting year. However, the correct Threshold Achievement is 90%. The number of shares reflected in column 7 assumes the maximum potential vest in each vesting year. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 17:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 17,307 | $4.11 | $71,131.77 |
DisclosureSEC source: 0000950170-25-022428 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,420 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.99 to $4.27. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 17:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 10,845 | $3.83 | $41,536.35 |
DisclosureSEC source: 0000950170-25-021398 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,727 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.74 to $3.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 17:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 14,836 | $3.28 | $48,662.08 |
DisclosureSEC source: 0000950170-25-018967 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,572 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.51 to $3.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 17:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 150,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-135873 · ownership.xml · derivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F1 · price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. F2 · derivative.expiration_date: Represents a PRSU award granted on December 10, 2024 and vesting on December 31, 2025, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended June 30, 2025; (ii) 50% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended September 30, 2025 and (iii) 25% of the award will be attained if the Issuer achieves Cash Flow Breakeven for the fiscal quarter ended December 31, 2025. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 17:05 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,368 | $0.82 | $1,121.76 |
DisclosureSEC source: 0000950170-24-114103 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,408 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $0.78 to $0.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 17:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-024005 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,776 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 28, 2025, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 17:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 3,985 | $3.16 | $12,592.60 |
DisclosureSEC source: 0000950170-24-023242 · ownership.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,776 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.95 to $3.31. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 17:02 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 21,272 | $3.33 | $70,835.76 |
DisclosureSEC source: 0000950170-24-023242 · ownership.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,761 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.21 to $3.43. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 18:00 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 14,710 | $3.51 | $51,632.10 |
DisclosureSEC source: 0001209191-24-003206 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 509,033 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.44 to $3.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 17:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 5,813 | $3.39 | $19,706.07 |
DisclosureSEC source: 0001209191-24-002957 · doc4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 523,743 F3 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the Reporting Person's tax withholding obligation upon vesting of a portion of a RSU award. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.22 to $3.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 17:41 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002957 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,556 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 5, 2025, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 06, 2023 Filed Oct 10, 2023 17:10 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,499 | $1.16 | $1,731.35 |
DisclosureSEC source: 0001062993-23-019208 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,556 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.10 to $1.16. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 16:08 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,079 | $4.59 | $50,852.61 |
DisclosureSEC source: 0001062993-23-006416 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · EVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,055 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $4.23 to $4.74. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 17:17 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 13,148 | $5.90 | $77,573.20 |
DisclosureSEC source: 0001062993-23-003807 · form4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,134 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.81 to $6.00. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:17 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,403 | $5.58 | $69,208.74 |
DisclosureSEC source: 0001062993-23-003807 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,282 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.41 to $5.72. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2023 Filed Feb 9, 2023 17:43 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008107 · doc4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,685 F3 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 8, 2024, in each case subject to continuous service of the Reporting Person through such date. F4 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 17:43 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 5,584 | $5.99 | $33,448.16 |
DisclosureSEC source: 0001209191-23-008107 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,685 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.93 to $6.06. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 16:58 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 16,050 | $6.13 | $98,386.50 |
DisclosureSEC source: 0001062993-23-001024 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,269 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $6.05 to $6.24. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 11, 2022 Filed Oct 12, 2022 16:25 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 1,630 | $2.97 | $4,841.10 |
DisclosureSEC source: 0001062993-22-020733 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389,319 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| July 25, 2022 Filed Jul 26, 2022 16:54 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 13,321 | $3.54 | $47,156.34 |
DisclosureSEC source: 0001062993-22-016712 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,949 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.48 to $3.58. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 09, 2022 Filed Mar 10, 2022 16:58 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 10,029 | $3.00 | $30,045.88 |
DisclosureSEC source: 0001062993-22-007332 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,270 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.96 to $3.05. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2022 Filed Feb 9, 2022 16:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 166 | $3.14 | $521.24 |
DisclosureSEC source: 0001062993-22-003328 · form4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,642 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 18:09 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 176,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-003823 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,299 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 9, 2023, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 16:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 5,184 | $3.12 | $16,198.96 |
DisclosureSEC source: 0001062993-22-003328 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,808 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.11 to $3.14. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 16:38 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 268 | $3.40 | $911.20 |
DisclosureSEC source: 0001062993-22-001537 · form4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,992 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation. Read SEC document |
| January 21, 2022 Filed Jan 25, 2022 16:38 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 17,189 | $3.62 | $62,224.18 |
DisclosureSEC source: 0001062993-22-001537 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,260 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.55 to $3.70. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 17:11 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-009266 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,449 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on October 4, 2022, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 16:45 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,563 | $13.08 | $85,844.04 |
DisclosureSEC source: 0001062993-21-006837 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,449 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $12.81 to $13.28. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 18:27 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 2,473 | $15.00 | $37,101.43 |
DisclosureSEC source: 0001062993-21-005461 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,012 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $15.00 to $15.01. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 21, 2021 Filed May 24, 2021 17:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,406 | $15.01 | $96,170.72 |
DisclosureSEC source: 0001062993-21-005010 · form4.xml · nonDerivative · entry 3 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,485 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $15.00 to $15.09. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 11,121 | $15.09 | $167,837.02 |
DisclosureSEC source: 0001062993-21-005010 · form4.xml · nonDerivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,891 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $15.00 to $15.33. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 20, 2021 Filed May 24, 2021 17:12 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 12,959 | $15.00 | $194,385.00 |
DisclosureSEC source: 0001062993-21-005010 · form4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,012 F1 · kind: These shares were sold in compliance with a trading plan adopted by the reporting person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 17:06 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 6,521 | $14.64 | $95,467.44 |
DisclosureSEC source: 0000925421-21-000108 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,971 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $14.14 to $15.06. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 17:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantPerformance Restricted Stock Unit · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000077 · edgar.xml · derivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F3 · derivative.exercise_price: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. F3 · derivative.exercise_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. F3 · derivative.expiration_date: Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of the Issuer's common stock. The PRSU rights vest upon the Issuer's common stock achieving a 30 day volume weighted average price of $25 per share. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 17:21 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 35,176 | $0.00 | $0.00 |
DisclosureSEC source: 0000925421-21-000077 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,492 F1 · shares: Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 3, 2022, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 21, 2021 Filed Jan 25, 2021 21:26 UTC | Neuronetics, Inc. STIM · Entity 6248 | SaleCommon Stock | 7,585 | $18.21 | $138,122.85 |
DisclosureSEC source: 0000925421-21-000052 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,316 F1 · shares: The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $17.52 to $19.49. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 19:55 UTC | Neuronetics, Inc. STIM · Entity 6248 | Tax withholdingCommon Stock | 5,283 | $2.81 | $14,845.23 |
DisclosureSEC source: 0001192482-20-000637 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,901 F1 · price: Represents the weighted average purchase price. The highest price at which shares were purchased was $2.85 and the lowest price at which shares were purchased was $2.78. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4. Read SEC document |
| March 10, 2020 Filed Mar 11, 2020 17:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 25,000 | $2.00 | $50,000.00 |
DisclosureSEC source: 0001192482-20-000214 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,184 F1 · price: Represents the weighted average purchase price. The highest price at which shares were purchased was $2.00 and the lowest price at which shares were purchased was $1.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions reported on this Form 4. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 17:30 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 65,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000194 · edgar.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,184 F1 · shares: Represents a restricted stock unit ("RSU") award of which 1/3 vests on each of the first, second and third anniversaries of the date of grant, in each case subject to continuous service of the Reporting Person through such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 16:31 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 95,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-004011 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,934 F1 · shares: One-third (1/3rd) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of January 15, 2021, January 15, 2022 and January 15, 2023, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 16:40 UTC | Neuronetics, Inc. STIM · Entity 6248 | PurchaseCommon Stock | 22,959 | $4.49 | $103,085.91 |
DisclosureSEC source: 0001209191-19-057195 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,934 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.4535 to $4.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 16:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantEmployee Stock Option (right to buy) · Derivative | 117,845 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001209191-19-043047 · doc4.xml · derivative · entry 2 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,845 Underlying: Common Stock · 117,845 shares Expires 2029-07-22 F3 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on July 22, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 16:33 UTC | Neuronetics, Inc. STIM · Entity 6248 | GrantCommon Stock | 60,975 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-043047 · doc4.xml · nonDerivative · entry 1 Furlong Stephen · CIK 0001783360 · CFO and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,975 F1 · shares: Twenty-five percent (25%) of the shares subject to the restricted stock unit ("RSU") grant shall vest on each of July 22, 2020 and July 22, 2021, and fifty percent (50%) of the shares subject to the RSU grant shall vest on July 22, 2022, subject to Reporting Person continuing to provide service through each such date. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.